We measured gene expression levels of RNASE1, JDP2, and FMN1 at the other time points after AMI (4 to 6 days, 1 month, 6 months) in HF, non-HF, and control groups from the study and validation groups (Figure 5). The gene discussed is RNASE1; the disease is hydrops fetalis.